Procter Gamble Health Ltd vs Wanbury Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 03, 2026

Key Highlights

The Latest Trading Price of Procter & Gamble Health Ltd is ₹ 5194 as of 30 Apr 15:30 . The P/E Ratio of Procter & Gamble Health Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Wanbury Ltd changed from 3.4 on March 2022 to 25.2 on March 2025 . This represents a CAGR of 65.00% over 4 years The Market Cap of Procter & Gamble Health Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Wanbury Ltd changed from ₹ 207.5 crore on March 2021 to ₹ 768.96 crore on March 2025 . This represents a CAGR of 29.95% over 5 years The revenue of Procter & Gamble Health Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Wanbury Ltd for the Jun '25 is ₹ 163.53 crore as compare to the Mar '25 revenue of ₹ 173.84 crore. This represent the decline of -5.93% The ebitda of Procter & Gamble Health Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Wanbury Ltd for the Jun '25 is ₹ 24.79 crore as compare to the Mar '25 ebitda of ₹ 31.47 crore. This represent the decline of -21.23% The net profit of Procter & Gamble Health Ltd changed from ₹ 0 crore to ₹ 0 crore over 5 quarters. This represents a CAGR of 0.0% The net profit of Wanbury Ltd changed from ₹ 1.04 crore to ₹ 13.49 crore over 5 quarters. This represents a CAGR of 676.93% The dividend payout of Procter & Gamble Health Ltd changed from 122.06 % to 0 % over 9 quarters. This represents a CAGR of -100.00% The dividend payout of Wanbury Ltd changed from 0 % to 0 % over 9 quarters. This represents a CAGR of 0.0% .

About Procter & Gamble Health Ltd

Procter & Gamble Health Limited was erstwhile incorporated as E Merck (India) Limited in 1967.
The Company's name was changed from E Merck (India) Limited to Merck Limited on March 27, 2002.
Later, the name of the Company was changed to Procter & Gamble Health Limited on 6 May, 2019.
The company was set up to take over the business of the Indian branch of Emeda Exports with all their assets and liabilities.
The company is a 51% subsidiary of German firm Merck KGaA, is a leading player in vitamin formulations. Procter & Gamble Health Limited is an Indian-based company principally engaged in the business of manufacturing and marketing of pharmaceuticals and chemicals.

About Wanbury Ltd

Wanbury Limited, formerly known Pearl Organics Limited was incorporated in August, 1988.
The Company attained its present name in September 2004.
The Company is engaged in the business of pharmaceutical and related activities, including research. The company has established its first plant in the year 1992 in Tarapur for manufacturing APIs.
In 1995, the Company acquired plant of Brij Chemicals Pvt Ltd at Patalganga.
In 1996, it entered into a strategic alliance with Wyckoff Chemicals to manufacture its API in US. In 2007-08, the merger of Doctors Organic Chemicals Limited (DOCL) with the Company became effective from 1st April, 2007.

FAQs for the comparison of Procter & Gamble Health Ltd and Wanbury Ltd

Which company has a larger market capitalization, Procter & Gamble Health Ltd or Wanbury Ltd?

Market cap of Procter & Gamble Health Ltd is 8,622 Cr while Market cap of Wanbury Ltd is 901 Cr

What are the key factors driving the stock performance of Procter & Gamble Health Ltd and Wanbury Ltd?

The stock performance of Procter & Gamble Health Ltd and Wanbury Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Procter & Gamble Health Ltd and Wanbury Ltd?

As of May 3, 2026, the Procter & Gamble Health Ltd stock price is INR ₹5194.55. On the other hand, Wanbury Ltd stock price is INR ₹257.9.

How do dividend payouts of Procter & Gamble Health Ltd and Wanbury Ltd compare?

To compare the dividend payouts of Procter & Gamble Health Ltd and Wanbury Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.